A synthetic peptide for use as a blocking control in assays to test for specificity of DNAJC19 antibody, Alternative Names: DNAJC19 control peptide, DNAJC19 antibody Blocking Peptide, Anti-DNAJC19 Blocking Peptide, DnaJ, Hsp40 homolog, subfamily C, member 19 Blocking Peptide, TIM14 Blocking Peptide, TIMM14 Blocking Peptide, DNAJC19, DNAJC-19, DNAJC 19, DNAJC-19 Blocking Peptide, DNAJC 19 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
DNAJC19
(DnaJ (Hsp40) Homolog, Subfamily C, Member 19 (DNAJC19))
Hintergrund
The protein encoded by this gene is thought to be part of a complex involved in the ATP-dependent transport of transit peptide-containing proteins from the inner cell membrane to the mitochondrial matrix. Defects in this gene are a cause of 3-methylglutaconic aciduria type 5 (MGA5), also known as dilated cardiomyopathy with ataxia (DCMA). Several transcript variants, some protein-coding and some not, have been found for this gene.